发明名称 |
LISTERIA-BASED IMMUNOGENIC COMPOSITIONS FOR ELICITING ANTI-TUMOR RESPONSES |
摘要 |
The present invention is directed to compositions comprising an immune checkpoint inhibitor or a T cell stimulator or a combination thereof, and a live attenuated recombinant Listeria strain comprising a fusion polypeptide comprising a truncated Listeriolysin O protein, a truncated ActA protein, or a PEST amino acid sequence fused to a tumor-associated antigen. The invention is further directed to methods of treating, protecting against, and inducing an immune response against a tumor or a cancer, comprising the step of administering the same. |
申请公布号 |
CA2955432(A1) |
申请公布日期 |
2016.01.21 |
申请号 |
CA20152955432 |
申请日期 |
2015.07.17 |
申请人 |
ADVAXIS, INC.;THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
发明人 |
PETIT, ROBERT;WALLECHA, ANU;KHLEIF, SAMIR;CHEN, ZHISONG;BERZOFSKY, JAY A. |
分类号 |
A61K39/02;A61K35/74;A61K39/12;A61P35/00 |
主分类号 |
A61K39/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|